LP
Lucid Peptides
Research Grade

Research Summary

BPC-157

Research Hub
Clinical — 10 studies

BPC-157 is a synthetic peptide derived from a fragment of human gastric juice that has been widely investigated in preclinical research models for tissue repair and cytoprotective effects.

Being studied for

Tendon and ligament healingGastrointestinal tissue protectionAngiogenesis and wound repair

Published Research

Evidence profile

Preclinical, with limited uncontrolled human reports

10 cited publications

Evidence gap: No controlled human trial was identified. The human reports are small, uncontrolled pilots in single clinical settings; the remaining evidence is animal and in-vitro.

Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.

Core evidence

The publications most central to understanding this compound.

ReviewNarrative review for clinicians

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians

Mayfield CK et al. · The American journal of sports medicine · 2026

A review of injectable peptide therapy written for orthopaedic and sports medicine practitioners, which examines the evidence base behind BPC-157 and related peptides and characterises how far it supports clinical use.

The authors' assessment of the evidence base
“While peptide therapy may possess significant therapeutic and regenerative potential, it is critical that orthopaedic and sports medicine providers understand the current lack of evidence to support the clinical use of these peptides.”

Context: A review, not new evidence. It is featured because it describes the size and quality of the evidence base.

PMID 41476424DOI 10.1177/03635465251357593
View on PubMed
ReviewNarrative review

From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management

Yuan C et al. · International journal of molecular sciences · 2026

Reviews the published BPC-157 literature across tissue repair and pain models, covering reported mechanisms alongside preparation standards, clinical validation and regulatory constraints.

The authors' assessment
“BPC-157 remains a promising candidate for regenerative medicine, yet comprehensive evaluation is required before clinical translation can be recommended.”

Context: Reviews a largely preclinical literature and adds no human data.

PMID 41898733DOI 10.3390/ijms27062876NCT02637284
View on PubMed

Supporting evidence

ClinicalUncontrolled pilot study in humans

Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study

Lee E et al. · Alternative therapies in health and medicine · 2024

Population: Patients with moderate to severe interstitial cystitis not responding to pentosan polysulfate

A small uncontrolled pilot administering BPC-157 into the bladder and reporting symptom change. One of very few human reports involving this compound.

Context: A pilot with no control arm and few participants, in one clinical context. It cannot establish an effect and does not generalise.

PMID 39325560
View on PubMed
PreclinicalControlled animal study

Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury

Yıldırım AK et al. · Scientific reports · 2026

Population: Rat model of lower-limb ischaemia-reperfusion injury

An animal study measuring oxidative stress, apoptosis, inflammation and angiogenesis markers in skeletal muscle after induced ischaemia-reperfusion injury.

Context: A rodent model. The findings describe that model and do not transfer to humans.

PMID 42204242DOI 10.1038/s41598-026-55449-1
View on PubMed
Additional indexed literature (6)

Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Lucid Peptides material. Citations verified against PubMed on 2026-08-09.

BPC-157 is an experimental compound studied in laboratory settings. It is not approved as a medicinal product for human use.

View full peptide profile for BPC-157
All Research
[Notice]All information on this page is provided strictly for laboratory research and educational purposes only.